Gemini Therapeutics

$11.24
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.23 (+2.09%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell GMTX and other stocks, options, and ETFs commission-free!

About GMTX

Gemini Therapeutics, Inc. Common Stock, also called Gemini Therapeutics, is a clinical-stage precision medicine company.

CEO
Jason Meyenburg
Employees
—
Headquarters
Cambridge, Massachusetts
Founded
2015
Market Cap
564.30M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
336.36K
High Today
$11.83
Low Today
$10.72
Open Price
$11.17
Volume
204.49K
52 Week High
$19.09
52 Week Low
$10.57

GMTX Earnings

Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected Jun 12, Pre-Market

You May Also Like

NSYS
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure